HAYAT PHARMACEUTICAL INDUSTRIES CO. Financial
Trading Information in the Regular Market
2020 | 2019 | 2018 | |
---|---|---|---|
Par Value/Share (JD) | 1.00 | 1.00 | 1.00 |
Closing Price (JD) | 2.42 | 1.96 | 1.93 |
Value Traded (JD) | 1,290,716 | 1,005,003 | 1,785,965 |
No. of Shares Traded | 608,214 | 535,272 | 846,874 |
No. of Transactions | 1,289 | 714 | 1,254 |
No. of Subscribed Shares | 9,500,000 | 9,500,000 | 9,500,000 |
Market Capitalization (JD) | 22,990,000 | 18,620,000 | 18,335,000 |
Fiscal Year Ended | 31/12/2020 | 31/12/2019 | 31/12/2018 |
Assets (JD)
2020 | 2019 | 2018 | |
---|---|---|---|
Cash on Hand & at Banks | 5,859,073 | 3,161,991 | 4,468,746 |
Accounts Receivable, Net | 6,810,729 | 6,287,559 | 5,558,241 |
Notes Receivable | 0 | 0 | 0 |
Post Dated Cheques | 3,297,078 | 2,197,144 | 2,189,802 |
Short Term Investments | 0 | 0 | 0 |
Inventory | 2,606,386 | 2,627,912 | 2,156,275 |
Spare Parts | 187,424 | 167,193 | 375,154 |
Total Current Assets | 19,257,913 | 15,003,717 | 16,122,160 |
Long Term Investments | 10 | 10 | 10 |
Fixed Assets, Net | 10,830,862 | 4,824,998 | 4,538,748 |
Lands | 1,879,381 | 1,879,381 | 1,879,381 |
Projects in Progress | 645,959 | 6,357,322 | 5,619,977 |
Total Fixed Assets | 13,356,202 | 13,061,701 | 12,038,106 |
Other Assets | 0 | 0 | 0 |
Total Assets | 32,614,125 | 28,065,428 | 28,160,276 |
Liabilities (JD)
2020 | 2019 | 2018 | |
---|---|---|---|
Accounts and Notes Payable | 2,372,006 | 1,396,063 | 2,652,415 |
Credit Banks | 0 | 2,439 | 711,127 |
Short Term Loans | 0 | 0 | 0 |
Accrued Part of Long Term Loans | 734,136 | 400,800 | 400,800 |
Total Current Liabilities | 4,701,852 | 3,087,252 | 4,838,985 |
Long Term Loans & Notes Payable | 1,438,316 | 1,064,800 | 1,469,791 |
Corporate Bonds | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | 6,140,168 | 4,152,052 | 6,308,776 |
Income Statement (JD)
2020 | 2019 | 2018 | |
---|---|---|---|
Operating Revenues | 16,580,369 | 15,644,027 | 14,118,798 |
Operating Expenses | 5,197,439 | 5,618,894 | 4,977,273 |
Gross Profit | 11,382,930 | 10,025,133 | 9,141,525 |
General and Administrative Expenses | 2,104,358 | 2,094,154 | 1,755,644 |
Selling and Distribution Expenses | 4,835,813 | 3,804,436 | 3,602,648 |
Depreciation (Period) | 479,054 | 464,287 | 583,258 |
Other Operating Expenses | 347,304 | 373,285 | 417,289 |
Net Operating Income | 4,095,455 | 3,753,258 | 3,365,944 |
Other Revenues | 115,362 | 151,763 | 169,568 |
Other Expenses | 0 | 0 | 0 |
Income Before Interest & Tax | 4,210,817 | 3,905,021 | 3,535,512 |
Interest Expenses | 107,246 | 120,299 | 121,652 |
Net Income Before Tax | 4,103,571 | 3,784,722 | 3,413,860 |
Income Tax (Period) | 569,379 | 417,846 | 235,358 |
Income Tax (Previous Years) | 0 | 0 | 0 |
Universities and Research Train Fees | 0 | 0 | 0 |
Board of Directors Remuniration | 23,611 | 35,000 | 35,000 |
Net Income | 3,510,581 | 3,331,876 | 3,143,502 |
Non-controlling Interest | 0 | 0 | 0 |
Net Income Pertains to Shareholders | 3,510,581 | 3,331,876 | 3,143,502 |
Cash Flow (JD)
2020 | 2019 | 2018 | |
---|---|---|---|
Cash Balance (Beginning) | 3,161,991 | 4,468,746 | 4,068,985 |
Net Cash Flow from (Used in) Operating Activities | 3,823,470 | 2,685,108 | 3,786,206 |
Net Cash Flow from (Used in) Investing Activities | -773,555 | -1,487,882 | -3,924,978 |
Net Cash Flow from (Used in) Financing Activities | -352,833 | -2,503,981 | 538,533 |
Cash Balance (Ending) | 5,859,073 | 3,161,991 | 4,468,746 |
Financial Ratios
2020 | 2019 | 2018 | |
---|---|---|---|
Turnover Ratio % | 6.402 | 5.634 | 8.915 |
Earning Per Share (JD) | 0.370 | 0.351 | 0.331 |
Dividend Per Share (JD) | 0.200 | 0.100 | 0.130 |
Book Value Per Share (JD) | 2.787 | 2.517 | 2.300 |
Price Earnings Ratio (Times) | 6.549 | 5.588 | 5.833 |
Dividend Yield % | 8.265 | 5.102 | 6.736 |
Dividend Per Share to Earning Per Share % | 54.122 | 28.513 | 39.287 |
Price to Book Value (Times) | 0.868 | 0.779 | 0.839 |
Gross Margin % | 68.653 | 64.083 | 64.747 |
Margin Before Interest and Tax % | 25.396 | 24.962 | 25.041 |
Profit Margin % | 21.173 | 21.298 | 22.265 |
Return On Assets % | 10.764 | 11.872 | 11.163 |
Return On Equity % | 13.261 | 13.933 | 14.386 |
Debt Ratio % | 18.827 | 14.794 | 22.403 |
Equity Ratio % | 81.173 | 85.206 | 77.597 |
Interest Coverage Ratio (Times) | 39.263 | 32.461 | 29.063 |
Total Assets Turnover (Times) | 0.508 | 0.557 | 0.501 |
Fixed Assets Turnover (Times) | 1.241 | 1.198 | 1.173 |
Working Capital Turnover (Times) | 1.139 | 1.313 | 1.251 |
Current Ratio (Times) | 4.096 | 4.860 | 3.332 |
Working Capital (JD) | 14,556,061.000 | 11,916,465.000 | 11,283,175.000 |